Alison Long
Director/Board Member at TAYSHA GENE THERAPIES, INC.
Net worth: - $ as of 2024-03-30
Profile
Alison Long is currently a Director at Taysha Gene Therapies, Inc. She was previously the Chief Medical Officer at Kaleido Biosciences, Inc. and the Chief Medical Officer & Senior Vice President at Freeline Therapeutics Holdings Plc.
Dr. Long holds a doctorate degree from George Mason University and the University of the Witwatersrand.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-10-31 | 0 ( -.--% ) | - $ | 2024-03-30 |
Alison Long active positions
| Companies | Position | Start |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Director/Board Member | 2023-10-31 |
Former positions of Alison Long
| Companies | Position | End |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2022-05-31 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 2021-10-31 |
Training of Alison Long
| George Mason University | Doctorate Degree |
| University of the Witwatersrand | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| TAYSHA GENE THERAPIES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Alison Long
